Cargando…
A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine
The murine intestinal nematode Heligmosomoides polygyrus releases the H. polygyrus Alarmin Release Inhibitor (HpARI) - a protein which binds to IL-33 and to DNA, effectively tethering the cytokine in the nucleus of necrotic cells. Previous work showed that a non-natural truncation consisting of the...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338556/ https://www.ncbi.nlm.nih.gov/pubmed/32695116 http://dx.doi.org/10.3389/fimmu.2020.01363 |
_version_ | 1783554705328177152 |
---|---|
author | Chauché, Caroline Vacca, Francesco Chia, Shin Li Richards, Josh Gregory, William F. Ogunkanbi, Adefunke Wear, Martin McSorley, Henry J. |
author_facet | Chauché, Caroline Vacca, Francesco Chia, Shin Li Richards, Josh Gregory, William F. Ogunkanbi, Adefunke Wear, Martin McSorley, Henry J. |
author_sort | Chauché, Caroline |
collection | PubMed |
description | The murine intestinal nematode Heligmosomoides polygyrus releases the H. polygyrus Alarmin Release Inhibitor (HpARI) - a protein which binds to IL-33 and to DNA, effectively tethering the cytokine in the nucleus of necrotic cells. Previous work showed that a non-natural truncation consisting of the first 2 domains of HpARI (HpARI_CCP1/2) retains binding to both DNA and IL-33, and inhibited IL-33 release in vivo. Here, we show that the affinity of HpARI_CCP1/2 for IL-33 is significantly lower than that of the full-length protein, and that HpARI_CCP1/2 lacks the ability to prevent interaction of IL-33 with its receptor. When HpARI_CCP1/2 was applied in vivo it potently amplified IL-33-dependent immune responses to Alternaria alternata allergen, Nippostrongylus brasiliensis infection and recombinant IL-33 injection, in direct contrast to the IL-33-suppressive effects of full-length HpARI. Mechanistically, we found that HpARI_CCP1/2 is able to bind to and stabilize IL-33, preventing its degradation and maintaining the cytokine in its active form. This study highlights the importance of IL-33 inactivation, the potential for IL-33 stabilization in vivo, and describes a new tool for IL-33 research. |
format | Online Article Text |
id | pubmed-7338556 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-73385562020-07-20 A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine Chauché, Caroline Vacca, Francesco Chia, Shin Li Richards, Josh Gregory, William F. Ogunkanbi, Adefunke Wear, Martin McSorley, Henry J. Front Immunol Immunology The murine intestinal nematode Heligmosomoides polygyrus releases the H. polygyrus Alarmin Release Inhibitor (HpARI) - a protein which binds to IL-33 and to DNA, effectively tethering the cytokine in the nucleus of necrotic cells. Previous work showed that a non-natural truncation consisting of the first 2 domains of HpARI (HpARI_CCP1/2) retains binding to both DNA and IL-33, and inhibited IL-33 release in vivo. Here, we show that the affinity of HpARI_CCP1/2 for IL-33 is significantly lower than that of the full-length protein, and that HpARI_CCP1/2 lacks the ability to prevent interaction of IL-33 with its receptor. When HpARI_CCP1/2 was applied in vivo it potently amplified IL-33-dependent immune responses to Alternaria alternata allergen, Nippostrongylus brasiliensis infection and recombinant IL-33 injection, in direct contrast to the IL-33-suppressive effects of full-length HpARI. Mechanistically, we found that HpARI_CCP1/2 is able to bind to and stabilize IL-33, preventing its degradation and maintaining the cytokine in its active form. This study highlights the importance of IL-33 inactivation, the potential for IL-33 stabilization in vivo, and describes a new tool for IL-33 research. Frontiers Media S.A. 2020-06-30 /pmc/articles/PMC7338556/ /pubmed/32695116 http://dx.doi.org/10.3389/fimmu.2020.01363 Text en Copyright © 2020 Chauché, Vacca, Chia, Richards, Gregory, Ogunkanbi, Wear and McSorley. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Chauché, Caroline Vacca, Francesco Chia, Shin Li Richards, Josh Gregory, William F. Ogunkanbi, Adefunke Wear, Martin McSorley, Henry J. A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine |
title | A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine |
title_full | A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine |
title_fullStr | A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine |
title_full_unstemmed | A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine |
title_short | A Truncated Form of HpARI Stabilizes IL-33, Amplifying Responses to the Cytokine |
title_sort | truncated form of hpari stabilizes il-33, amplifying responses to the cytokine |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338556/ https://www.ncbi.nlm.nih.gov/pubmed/32695116 http://dx.doi.org/10.3389/fimmu.2020.01363 |
work_keys_str_mv | AT chauchecaroline atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT vaccafrancesco atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT chiashinli atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT richardsjosh atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT gregorywilliamf atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT ogunkanbiadefunke atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT wearmartin atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT mcsorleyhenryj atruncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT chauchecaroline truncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT vaccafrancesco truncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT chiashinli truncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT richardsjosh truncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT gregorywilliamf truncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT ogunkanbiadefunke truncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT wearmartin truncatedformofhparistabilizesil33amplifyingresponsestothecytokine AT mcsorleyhenryj truncatedformofhparistabilizesil33amplifyingresponsestothecytokine |